CASTLE BIOSCIENCES, INC. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CASTLE BIOSCIENCES, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-03-31 was $1.90M, a 9.10% increase year-over-year.
- CASTLE BIOSCIENCES, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $978.00K, a 3.60% increase year-over-year.
- CASTLE BIOSCIENCES, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-03-31 was $1.74M, a 1.70% increase year-over-year.
- CASTLE BIOSCIENCES, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-09-30 was $944.00K, a 11.11% decline year-over-year.
- CASTLE BIOSCIENCES, INC. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $2.72M, a 2.45% increase from fiscal 2024.
- CASTLE BIOSCIENCES, INC. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $2.65M, a 2.28% decline from fiscal 2023.
- CASTLE BIOSCIENCES, INC. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $2.71M, a 15.39% increase from fiscal 2022.
- CASTLE BIOSCIENCES, INC. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $2.35M, a 12.64% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-03-31 | $1.90M 10-Q · filed 2026-07-30 | |
| 2025-12-31 | $2.72M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $978.00K 10-Q · filed 2025-11-03 | |
| 2025-03-31 | $1.74M 10-Q · filed 2026-07-30 | |
| 2024-12-31 | $2.65M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $944.00K 10-Q · filed 2025-11-03 | |
| 2024-03-31 | $1.71M 10-Q · filed 2025-11-03 | |
| 2023-12-31 | $2.71M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $1.06M 10-Q · filed 2024-11-04 | |
| 2023-03-31 | $1.65M 10-Q · filed 2024-11-04 | |
| 2022-12-31 | $2.35M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $895.00K 10-Q · filed 2023-11-02 | |
| 2022-03-31 | $1.46M 10-Q · filed 2023-11-02 | |
| 2021-12-31 | $2.09M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $855.00K 10-Q · filed 2022-11-02 | |
| 2021-03-31 | $1.23M 10-Q · filed 2022-11-02 | $1.93M derived: sum of 4 quarters · filed 2022-11-02 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $1.30M 10-K · filed 2022-02-28 |
| 2020-09-30 | $693.00K 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | |
| 2020-03-31 | $603.00K 10-Q · filed 2021-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |